昌平合成生物企业同比增长近七成

Core Insights - The synthetic biology manufacturing industry in Changping District is experiencing significant growth, with the number of enterprises increasing by nearly 70% compared to the same period in 2025 [1][2] - The industry is moving towards a cluster development phase, with a target to establish 10 landmark synthetic biology projects by 2026 and achieve an industry revenue exceeding 10 billion yuan [2] Group 1: Company Developments - Micro Yuan Synthetic Biology Technology (Beijing) Co., Ltd. has successfully commercialized products such as mannitol, allulose, and xylitol, focusing on various product lines including human nutrition, animal nutrition, daily chemical raw materials, and pharmaceutical excipients [1] - The company has grown from a few employees to a team of several hundred, with over 60% being research and development personnel [1] Group 2: Industry Growth and Goals - As of now, there are 146 synthetic biology manufacturing enterprises established in Changping, with ongoing efforts in subfields such as bio-based new materials, collagen, biological breeding, and gas fermentation [2] - The Changping District aims to transition from regional leadership to national influence, establishing itself as a significant source of innovation and industry leadership in synthetic biology manufacturing [2]